FDA Warns California Drugmaker for Testing Deficiencies, Missing Quality Unit

The FDA issued a warning to bB Biochem Laboratories for unsupported product expiration dates, a failure to test incoming raw materials and for having no quality unit.
Source: Drug Industry Daily